Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000898432-20-000814
Filing Date
2020-10-14
Accepted
2020-10-14 18:53:48
Documents
1
Period of Report
2020-10-13

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 11852
  Complete submission text file 0000898432-20-000814.txt   13584
Mailing Address 801 WEST 10TH STREET SUITE 302 JUNEAU AK 99801
Business Address 801 WEST 10TH STREET SUITE 302 JUNEAU AK 99801 907-796-1500
Alaska Permanent Fund Corp (Reporting) CIK: 0001582681 (see all company filings)

State of Incorp.: AK | Fiscal Year End: 0630
Type: 3 | Act: 34 | File No.: 001-39615 | Film No.: 201239978

Mailing Address C/O ARCH VENTURE PARTNERS 999 THIRD AVENUE, SUITE 3400 SEATTLE WA 98104
Business Address C/O ARCH VENTURE PARTNERS 999 THIRD AVENUE, SUITE 3400 SEATTLE WA 98104 857-400-4222
Codiak BioSciences, Inc. (Issuer) CIK: 0001659352 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)